Match tier Listed
Presence Formerly Arkansas
Last published 2025
Sources OpenAlex · ORCID
Refreshed 2026-10-06

Mohammad Pakravan

High Impact

Associate Professor

Also affiliated: Yahoo (United Kingdom) (2007); Johns Hopkins University (2006); Shiraz University of Medical Sciences (2024); Financial University (2007); American Academy of Dermatology (2007); Johns Hopkins Medicine (2006); Imam Khomeini Hospital (2005–2014); Mofid University (2007); Ophthalmic Research Institute of Australia (2014–2022); King Khaled Eye Specialist Hospital (2015); Jones Institute (2023); Johns Hopkins Hospital (2006); Hospital Labbafinejad (2007–2012); Shahid Beheshti University (2008–2020); The University of Texas Medical Branch at Galveston (2024); Shahid Beheshti University of Medical Sciences (2007–2022); Tehran University of Medical Sciences (2007–2018)

Formerly Arkansas Affiliated with UAMS through 2024; recent publications list Shahid Beheshti University of Medical Sciences, Tehran University of Medical Sciences.

25 h-index 145 pubs 2,440 cited

  • Humans
  • Male
  • Female
  • Intraocular Pressure
  • Middle Aged
  • Adult
  • Glaucoma
  • Aged
  • Glaucoma Drainage Implants
  • Visual Acuity
  • Tonometry, Ocular
  • Treatment Outcome
  • Trabeculectomy
  • Glaucoma, Open-Angle
  • Prospective Studies

Biography and Research Information

OverviewAI-generated summary

Mohammad Pakravan's research focuses on ophthalmology, with a particular emphasis on glaucoma and related conditions. His work has investigated genetic associations with exfoliation syndrome, a significant risk factor for glaucoma, identifying both protective and susceptibility loci. He has also explored the relationship between central corneal thickness and optic disc size as potential contributors to glaucoma susceptibility.

Pakravan's clinical research includes evaluating surgical interventions for glaucoma. He has examined the efficacy of adjunctive treatments such as mitomycin C and amniotic membrane transplantation in conjunction with Ahmed Glaucoma Valve implantation. Additionally, his studies have assessed the use of intravitreal bevacizumab for neovascular glaucoma and compared trabeculectomy with mitomycin C to Ahmed Glaucoma Implant with mitomycin C for pediatric aphakic glaucoma.

With 145 publications and an h-index of 25, Pakravan is recognized as a highly cited researcher. He leads a research group at the University of Arkansas for Medical Sciences and collaborates with other faculty members, including Ahmed B. Sallam, Jamal O. Azhari, and Abdelrahman M. Elhusseiny.

Metrics

  • h-index: 25
  • Publications: 145
  • Citations: 2,440

Positions

  • Associate Professor publications 2022–2024
    University of Arkansas for Medical Sciences Institution web page

Selected Publications

  • Clinical outcomes of radial optic neurotomy versus pars plana vitrectomy in recent onset non-arteritic anterior ischemic optic neuropathy (2024)
    European Journal of Ophthalmology DOI OpenAlex
  • Ahmed and Baerveldt Glaucoma Drainage Devices in Childhood Glaucoma: A Meta-Analysis (2023)
    Journal of Glaucoma 15 citations DOI OpenAlex
  • The Role of Optical Coherence Tomography Angiography in Optic Nerve Head Edema: A Narrative Review (2022)
    Journal of Ophthalmology 5 citations DOI OpenAlex
  • Influence of Near Vision Tasks on Intraocular Pressure in Normal Subjects and Glaucoma Patients (2022)
    Journal of Ophthalmic and Vision Research 5 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

28 Collaborators 12 Institutions 5 Countries

Top Collaborators

Similar Researchers

Based on overlapping research topics